EHDN Platform Meeting in collaboration with HDYO and EHA on uniQure topline results: Unpacking the outcomes so far

 
📅 Date: Tuesday, 18th November 2025
🕓 Time: 17:00-18:30 CET
📍 Format: Virtual (Zoom)

There is still time to register!

Register now

 

Since the release of uniQure’s topline results from the AMT-130 gene therapy trial — followed by further updates in recent weeks — there has been widespread interest across the Huntington’s disease community. This EHDN Platform Meeting, organised in collaboration with HDYO and EHA, will bring together leading experts and advocates to unpack what the results tell us so far and what they may mean for the field — scientifically, clinically, and for families impacted by HD.
Presentations by Prof. Anne Rosser and Prof. Sarah Tabrizi will be followed by a panel discussion chaired by Prof. Åsa Petersén, offering scientific and community perspectives on the recent results and reflecting on the current state of play.

Find out more about the panelists below: